Cancer Therapy News and Research

RSS

Many young cancer patients do not receive oncofertilty related services, new analysis finds

All cancer patients of reproductive age should be provided with fertility information and referrals for fertility preservation. A new Psycho-Oncology analysis of the published literature indicates that many cancer patients are not receiving such support, however.

21 Aug 2017

Study: More than 80% of women at risk for breast, ovarian cancer have not taken simple genetic test

Of the nearly 4 million women in the United States who have had either breast cancer or ovarian cancer, at least 1.5 million have a high risk of carrying certain types of genetic mutations that could increase their risk for additional cancers in the future.

21 Aug 2017

Combination treatment effectively vaccinates mice against cancer

By combining an FDA-approved cancer immunotherapy with an emerging tumor-roasting nanotechnology, Duke University researchers improved the efficacy of both therapies in a proof-of-concept study using mice.

18 Aug 2017

Women’s decision-making habits combined with values impact choice of breast cancer treatment

A new study finds that more than half of women with early stage breast cancer considered an aggressive type of surgery to remove both breasts.

17 Aug 2017

Chapman University's School of Pharmacy wins more than $3.5 million through 30 research awards

Chapman University’s four-year-old School of Pharmacy continues its aggressive growth in federal grant awards.

16 Aug 2017

Blood biopsy helps identify targetable genetic alterations in patients with cancer of unknown primary

Using fragments of circulating tumor DNA in blood, University of California San Diego School of Medicine researchers were able to identify theoretically targetable genetic alterations in 66 percent of patients with cancer of unknown primary (CUP), a rare disease with seven to 12 cases per 100,000 people each year.

16 Aug 2017

Cancer treatment with alternative medicine can double risk of dying: Study finds

A new study has found that patients who choose cancer treatment with alternative medicine more than double the risk of dying in five years compared to those who chose conventional cancer treatment for the treatable cancers. The study is published in the Journal of the National Cancer Institute.

15 Aug 2017

Mayo Clinic researchers discover new cause of treatment resistance in prostate cancer

Mayo Clinic researchers have identified a new cause of treatment resistance in prostate cancer. Their discovery also suggests ways to improve prostate cancer therapy. The findings appear in Nature Medicine.

14 Aug 2017

Alternative medicine use instead of proven cancer therapies results in worse survival

Patients who choose to receive alternative therapy as treatment for curable cancers instead of conventional cancer treatment have a higher risk of death, according to researchers from the Cancer Outcomes, Public Policy and Effectiveness Research Center at Yale School of Medicine and Yale Cancer Center.

11 Aug 2017

NYITCOM research could potentially lead to more effective, less toxic cancer treatment

Patients undergoing conventional chemotherapy for certain cancers could potentially receive more effective and less toxic drug treatment.

9 Aug 2017

Scientists identify 'killer peptide' released by diverse therapy-sensitive cancer cells

A new study by University of Kentucky Markey Cancer Center researchers shows that when therapy-sensitive cancer cells die, they release a "killer peptide" that can eliminate therapy-resistant cells.

9 Aug 2017

Potential drug offers hope for therapy-resistant breast cancer patients

UT Southwestern Simmons Cancer Center researchers have shown that a first-in-class molecule can prevent breast cancer growth when traditional therapies stop working.

8 Aug 2017

Discovery of new biological pathway involved in pain processing offers hope for new treatments

The discovery of a new biological pathway involved in pain processing offers hope of using existing cancer drugs to replace the use of opioids in chronic pain treatment, according to scientists at McGill University.

8 Aug 2017

Researchers find clues to how chemotherapy drug fuels cancer spread from the breast to lungs

The very same treatment that thwarts breast cancer has a dark side – it can fuel the spread of the disease to the lungs.

8 Aug 2017

Gold shines bright in cancer therapy research: New Edinburgh University study

According to latest research, gold particles can be effective in certain cancer therapy areas. Researchers at the Edinburgh University report in their new study that gold particles can help enhance the effectiveness of the agents used for lung cancer cells. The study is published in the scientific journal Angewandte Chemie.

8 Aug 2017

Tiny medical device containing gold specks could boost effects of cancer drugs

A tiny medical device containing gold specks could boost the effects of cancer medication and reduce its harm, research suggests.

7 Aug 2017

Researchers reveal potential of radiomics to improve precision medicine

Precision medicine has become the leading innovation of cancer treatment. Patients are routinely treated with drugs that are designed to target specific tumors and molecules.

3 Aug 2017

Breast cancer patients treated with targeted radiotherapy experience fewer side effects

Breast cancer patients who have radiotherapy targeted at the original tumour site experience fewer side effects five years after treatment than those who have whole breast radiotherapy, and their cancer is just as unlikely to return, according to trial results published in The Lancet today (Wednesday).

3 Aug 2017

SNMMI recognizes contributions to nuclear medicine and molecular imaging at 2017 annual meeting

The Society of Nuclear Medicine and Molecular Imaging (SNMMI), an international scientific and medical organization, recognized contributions to the field of nuclear medicine and molecular imaging during its 2017 Annual Meeting in Denver, Colorado. Several awards ceremonies were held to recognize the valuable role SNMMI members play in advancing the diagnosis and treatment of heart disease, cancer and neurological conditions.

2 Aug 2017

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

The U.S. Food and Drug Administration (FDA) yesterday in a press release informed about the approval of Imbruvica (ibrutinib) for the treatment of adult patients with chronic graft versus host disease (cGVHD) who have previously failed with one or more treatment. This is the first drug that the FDA has given its approval to in this disease condition.

2 Aug 2017

Cancer Therapy News and Research

Many young cancer patients do not receive oncofertilty related services, new analysis finds

Study: More than 80% of women at risk for breast, ovarian cancer have not taken simple genetic test

Combination treatment effectively vaccinates mice against cancer

Women’s decision-making habits combined with values impact choice of breast cancer treatment

Chapman University's School of Pharmacy wins more than $3.5 million through 30 research awards

Blood biopsy helps identify targetable genetic alterations in patients with cancer of unknown primary

Cancer treatment with alternative medicine can double risk of dying: Study finds

Mayo Clinic researchers discover new cause of treatment resistance in prostate cancer

Alternative medicine use instead of proven cancer therapies results in worse survival

NYITCOM research could potentially lead to more effective, less toxic cancer treatment

Scientists identify 'killer peptide' released by diverse therapy-sensitive cancer cells

Potential drug offers hope for therapy-resistant breast cancer patients

Discovery of new biological pathway involved in pain processing offers hope for new treatments

Researchers find clues to how chemotherapy drug fuels cancer spread from the breast to lungs

Gold shines bright in cancer therapy research: New Edinburgh University study

Tiny medical device containing gold specks could boost effects of cancer drugs

Researchers reveal potential of radiomics to improve precision medicine

Breast cancer patients treated with targeted radiotherapy experience fewer side effects

SNMMI recognizes contributions to nuclear medicine and molecular imaging at 2017 annual meeting

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

Event guide: 7th Allogeneic Cell Therapies Summit eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News